Australia markets closed

Bioxyne Limited (BXN.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0210-0.0030 (-12.50%)
At close: 01:03PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 16.63M
Enterprise value 14.88M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.62
Price/book (mrq)8.81
Enterprise value/revenue 6.16
Enterprise value/EBITDA -80.06

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 34.35%
S&P500 52-week change 3-10.18%
52-week high 30.0290
52-week low 30.0110
50-day moving average 30.0246
200-day moving average 30.0178

Share statistics

Avg vol (3-month) 3161.3k
Avg vol (10-day) 321.25k
Shares outstanding 5665.64M
Implied shares outstanding 6N/A
Float 8237.56M
% held by insiders 162.39%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 319 Mar 2012

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022


Profit margin -9.52%
Operating margin (ttm)-6.14%

Management effectiveness

Return on assets (ttm)-3.40%
Return on equity (ttm)-12.21%

Income statement

Revenue (ttm)2.48M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)1.22M
EBITDA -141.59k
Net income avi to common (ttm)-236.51k
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.17M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.87
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)435.02k
Levered free cash flow (ttm)443.64k